Fidelity Investments’s Olema Pharmaceuticals OLMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$120K Buy
28,241
+26,426
+1,456% +$113K ﹤0.01% 3529
2025
Q1
$6.82K Sell
1,815
-44,013
-96% -$165K ﹤0.01% 4609
2024
Q4
$267K Buy
45,828
+43,927
+2,311% +$256K ﹤0.01% 3158
2024
Q3
$22.7K Buy
1,901
+865
+83% +$10.3K ﹤0.01% 4116
2024
Q2
$11.2K Buy
1,036
+40
+4% +$433 ﹤0.01% 4290
2024
Q1
$11.3K Buy
996
+88
+10% +$996 ﹤0.01% 4227
2023
Q4
$12.7K Sell
908
-728
-44% -$10.2K ﹤0.01% 4158
2023
Q3
$20.2K Buy
1,636
+972
+146% +$12K ﹤0.01% 3796
2023
Q2
$6K Sell
664
-8
-1% -$72 ﹤0.01% 4309
2023
Q1
$2.33K Sell
672
-24
-3% -$83 ﹤0.01% 4590
2022
Q4
$1.71K Buy
696
+342
+97% +$838 ﹤0.01% 4551
2022
Q3
$1K Sell
354
-3,579
-91% -$10.1K ﹤0.01% 4717
2022
Q2
$16K Sell
3,933
-104,712
-96% -$426K ﹤0.01% 3962
2022
Q1
$463K Sell
108,645
-454,209
-81% -$1.94M ﹤0.01% 3010
2021
Q4
$5.27M Sell
562,854
-44,197
-7% -$414K ﹤0.01% 2351
2021
Q3
$16.7M Sell
607,051
-35,700
-6% -$984K ﹤0.01% 1924
2021
Q2
$18M Sell
642,751
-9,946
-2% -$278K ﹤0.01% 1886
2021
Q1
$21.7M Sell
652,697
-1,800
-0.3% -$59.7K ﹤0.01% 1772
2020
Q4
$31.5M Buy
+654,497
New +$31.5M ﹤0.01% 1509